Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Short-term Investments (2023 - 2026)

Collegium Pharmaceutical has reported Short-term Investments over the past 3 years, most recently at $19.8 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 20.6% year-over-year to $19.8 million; the TTM value through Dec 2025 reached $19.8 million, down 20.6%, while the annual FY2025 figure was $19.8 million, 20.6% down from the prior year.
  • Short-term Investments for Q4 2025 was $19.8 million at Collegium Pharmaceutical, down from $135.8 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $135.8 million in Q3 2025 and troughed at $19.8 million in Q4 2025.
  • A 3-year average of $74.1 million and a median of $81.0 million in 2024 define the central range for Short-term Investments.
  • On a YoY basis, Short-term Investments climbed as much as 136.66% in 2024 and fell as far as 65.08% in 2024.
  • Year by year, Short-term Investments stood at $71.6 million in 2023, then tumbled by 65.08% to $25.0 million in 2024, then decreased by 20.6% to $19.8 million in 2025.
  • Business Quant data shows Short-term Investments for COLL at $19.8 million in Q4 2025, $135.8 million in Q3 2025, and $104.8 million in Q2 2025.